Clinical Trials
0
Active:0
Completed:0
Trial Phases
0 Phases
Drug Approvals
74
NMPA:74
Drug Approvals
Valsartan Dispersible Tablets
- Product Name
- 缬沙坦分散片
- Approval Number
- 国药准字H20090319
- Approval Date
- May 11, 2024
NMPA
Scopolamine Hydrobromide Injection
- Product Name
- 氢溴酸东莨菪碱注射液
- Approval Number
- 国药准字H20033250
- Approval Date
- Jul 15, 2022
NMPA
Ranitidine Hydrochloride Injection
- Product Name
- 盐酸雷尼替丁注射液
- Approval Number
- 国药准字H20033880
- Approval Date
- Jul 15, 2022
NMPA
Lincomycin Hydrochloride Injection
- Product Name
- 盐酸林可霉素注射液
- Approval Number
- 国药准字H37020969
- Approval Date
- Jul 15, 2022
NMPA
Tranexamic Acid Injection
- Product Name
- 氨甲环酸注射液
- Approval Number
- 国药准字H20057885
- Approval Date
- Nov 22, 2021
NMPA
Tranexamic Acid Injection
- Product Name
- 氨甲环酸注射液
- Approval Number
- 国药准字H20057886
- Approval Date
- Nov 22, 2021
NMPA
- Prev
- 1
- 2
- 3
- 4
- 5
- 8
- Next
Clinical Trials
No trials found
News
No news found